🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Clariant faces sanctions over alleged reporting breaches

Published 03/03/2023, 06:28
Updated 03/03/2023, 09:57
© Reuters. FILE PHOTO: The logo of Swiss specialty chemicals company Clariant is seen at the company's headquarters in Pratteln, Switzerland August 9, 2017.  REUTERS/Arnd Wiegmann
CLN
-
CLZNY
-

ZURICH (Reuters) -Swiss specialty chemical maker Clariant is facing sanctions concerning alleged violations of financial reporting regulations, SIX Exchange Regulation (SER) said on Friday.

Clariant's 2020 and 2021 IFRS annual financial statements contained misstatements, said SER, which monitors compliance with legal and regulatory requirements for the Swiss stock exchange.

The alleged errors relate to the recognition of unjustified provisions in the 2020 IFRS financial statements and insufficient disclosures in connection with the correction of those errors in the 2021 statements, SER said.

"For this reason SER has submitted a request for a sanction to the Sanctions Commission of SIX Group against Clariant Ltd on 2 March 2023," SER said in a statement.

Clariant delayed the release of its 2021 results in February 2022 as investigators looked into allegations that some staff manipulated accounts in 2020 and 2021 to help meet financial targets.

The inquiry, triggered by whistleblowers, found no impact on sales and cash previously reported, although it replaced its chief financial officer "to allow for a fresh start".

A Clariant spokesperson said SIX was investigating in the general context of the postponement including both ad-hoc duty and financial reporting.

"This was to be expected and does not come as a surprise. Of course we are working together with the SIX in full transparency," the spokesperson said.

© Reuters. FILE PHOTO: The logo of Swiss specialty chemicals company Clariant is seen at the company's headquarters in Pratteln, Switzerland August 9, 2017.  REUTERS/Arnd Wiegmann

The proceedings are separate to an investigation by SER into Clariant for a potential violation of the rules on ad hoc publicity, SER said.

SER said it would provide no further information while proceedings are ongoing.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.